Identification of peroxiredoxin-1 as a novel biomarker of abdominal aortic aneurysm

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 31, Issue 4, 2011, Pages 935-943

  Martinez Pinna, Roxana ^a   Ramos Mozo, Priscila ^a   Madrigal Matute, Julio ^a   Blanco Colio, Luis M ^a   Lopez, Juan A ^b   Calvo, Enrique ^b   Camafeita, Emilio ^b   Lindholt, Jes S ^c   Meilhac, Olivier ^d,e,f   Delbosc, Sandrine ^d,e,f   Michel, Jean Baptiste ^d,e,f   De Ceniga, Melina Vega ^g   Egido, Jesus ^a   Martin Ventura, Jose L ^a,h  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^c VIBORG HOSPITAL   (Denmark)

^d INSERM   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f Section of Radiology   (France)

^g HOSPITAL DE GALDAKAO   (Spain)

^h UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

aneurysms; antioxidants; proteomics

Indexed keywords

MYELOPEROXIDASE; PEROXIREDOXIN 1;

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; BLOOD VESSEL DIAMETER; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL ELECTROPHORESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MASS SPECTROMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEOMICS; WESTERN BLOTTING;

AGED; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DENMARK; DISEASE PROGRESSION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; OXIDATIVE STRESS; PEROXIREDOXINS; PROSPECTIVE STUDIES; PROTEOMICS; ROC CURVE; SPAIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; UP-REGULATION;

EID: 79953737527     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.110.214429     Document Type: Article

References (34)

1. Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet. 2005;365:1577-1589. (Pubitemid 40615407)
2. Urbonavicius S, Urbonaviciene G, Honore B, Henneberg EW, Vorum H, Lindholt JS. Potential circulating biomarkers for abdominal aortic aneurysm expansion and rupture: a systematic review. Eur J Vasc Endovasc Surg. 2008;36:273-280.
3. Golledge J, Tsao PS, Dalman RL, Norman PE. Circulating markers of abdominal aortic aneurysm presence and progression. Circulation. 2008; 118:2382-2392.
4. Blanco-Colio LM, López JA, Martínez-Pinna Albar R, Egido J, Martín-Ventura JL. Vascular proteomics, a translational approach: from traditional to novel proteomic techniques. Expert Rev Proteomics. 2009;6: 461-464.
5. Nordon I, Brar R, Hinchliffe R, Cockerill G, Loftus I, Thompson M. The role of proteomic research in vascular disease. J Vasc Surg. 2009;49: 1602-16012.
6. Blanco-Colio LM, Martín-Ventura JL, Muñóz- García B, Orbe J, Páramo JA, Michel JB, Ortiz A, Meilhac O, Egido J. Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27:916-922. (Pubitemid 46606725)
7. Martin-Ventura JL, Duran MC, Blanco-Colio LM, Meilhac O, Leclercq A, Michel JB, Jensen ON, Hernandez-Merida S, Tuñón J, Vivanco F, Egido J. Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation. 2004; 110:2216-2219. (Pubitemid 39372504)
8. Fontaine V, Touat Z, Mtairag el M, Vranckx R, Louedec L, Houard X, Andreassian B, Sebbag U, Palombi T, Jacob MP, Meilhac O, Michel JB. Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus. Am J Pathol. 2004;164:2077-2087. (Pubitemid 38669355)
9. Caligiuri G, Rossignol P, Julia P, Groyer E, Mouradian D, Urbain D, Misra N, Ollivier V, Sapoval M, Boutouyrie P, Kaveri SV, Nicoletti A, Lafont A. Reduced immunoregulatory CD31α T cells in patients with atherosclerotic abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 2006;26:618-623.
10. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc. 2006;1:2856-2860.
11. Schuerenberg M, Luebbert C, Eickhoff H, Kalkum M, Lehrach H, Nordhoff E. Prestructured MALDI-MS sample supports. Anal Chem. 2000;72:3436-3442. (Pubitemid 30614913)
12. Suckau D, Resemann A, Schuerenberg M, Hufnagel P, Franzen J, Holle A. A novel MALDI LIFT-TOF/TOF mass spectrometer for proteomics. Anal Bioanal Chem. 2003;376:952-965. (Pubitemid 40877913)
13. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis. 1999;20:3551-3567. (Pubitemid 30007252)
14. Vega de Ceniga M, Esteban M, Quintana JM, Barba A, Estallo L, de la Fuente N, Viviens B, Martin-Ventura JL. Search for serum biomarkers associated with abdominal aortic aneurysm growth: a pilot study. Eur J Vasc Endovasc Surg. 2009;37:297-299.
15. Lindholt JS, Juul S, Fasting H, Henneberg EW. Screening for abdominal aortic aneurysms: single centre randomised controlled trial. BMJ. 2005; 330:750.
16. Lindholt JS, Vammen S, Juul S, Henneberg EW, Fasting H. The validity of ultrasonographic scanning as screening method for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 1999;17:472-475. (Pubitemid 29296745)
17. Neumann CA, Krause DS, Carman CV, Das S, Dubey DP, Abraham JL, Bronson RT, Fujiwara Y, Orkin SH, Van Etten RA. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature. 2003;424:561-565. (Pubitemid 36975778)
18. Houard X, Touat Z, Ollivier V, Louedec L, Philippe M, Sebbag U, Meilhac O, Rossignol P, Michel JB. Mediators of neutrophil recruitment in human abdominal aortic aneurysms. Cardiovasc Res. 2009;82: 532-541.
19. Houard X, Rouzet F, Touat Z, Philippe M, Dominguez M, Fontaine V, Sarda-Mantel L, Meulemans A, Le Guludec D, Meilhac O, Michel JB. Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms. J Pathol. 2007;212:20-28. (Pubitemid 46746286)
20. Kazi M, Thyberg J, Religa P, Roy J, Eriksson P, Hedin U, Swedenborg J. Influence of intraluminal thrombus on structural and cellular composition of abdominal aortic aneurysm wall. J Vasc Surg. 2003;38: 1283-1292. (Pubitemid 37517657)
21. Al-Barjas HS, Ariëns R, Grant P, Scott JA. Raised plasma fibrinogen concentration in patients with abdominal aortic aneurysm. Angiology. 2006;57:607-614. (Pubitemid 44564317)
22. McCormick ML, Gavrila D, Weintraub NL. Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2007;27:461-469.
23. Balla J, Vercellotti GM, Jeney V, Yachie A, Varga Z, Jacob HS, Eaton JW, Balla G. Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and dies) in an iron-rich environment. Antioxid Redox Signal. 2007;9:2119-2137. (Pubitemid 350059014)
24. Dubick MA, Keen CL, DiSilvestro RA, Eskelson CD, Ireton J, Hunter GC. Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease. Proc Soc Exp Biol Med. 1999;220:39-45.
25. Martinez-Pinna R, Lindholt JS, Blanco-Colio LM, Dejouvencel T, Madrigal-Matute J, Ramos-Mozo P, Vega de Ceniga M, Michel JB, Egido J, Meilhac O, Martin-Ventura JL. Increased levels of thioredoxin in patients with abdominal aortic aneurysms (AAA): a potential link of oxidative stress with AAA evolution. Atherosclerosis. 2010;212: 333-338.
26. Leavey PJ, Gonzalez-Aller C, Thurman G, Kleinberg M, Rinckel L, Ambruso DW, Freeman S, Kuypers FA, Ambruso DR. A 29-kDa protein associated with p67phox expresses both peroxiredoxin and phospholipase A2 activity and enhances superoxide anion production by a cell-free system of NADPH oxidase activity. J Biol Chem. 2002;277:45181-45187. (Pubitemid 36159121)
27. Wood ZA, Schroder E, Harris JR, Poole LB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci. 2003;28:32-40. (Pubitemid 36051004)
28. Mowbray AL, Kang DH, Rhee SG, Kang SW, Jo H. Laminar shear stress up-regulates peroxiredoxins (PRX) in endothelial cells: PRX 1 as a mechanosensitive antioxidant. J Biol Chem. 2008;83:1622-1627.
29. Wood ZA, Poole LB, Karplus PA. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science. 2003;300:650-653. (Pubitemid 36520591)
30. Riddell JR, Wang XY, Minderman H, Gollnick SO. Peroxiredoxin 1 Stimulates Secretion of Proinflammatory Cytokines by Binding to TLR4. J Immunol. 2010;184:1022-1030.
31. Kudrin A, Ray D. Cunning factor: macrophage migration inhibitory factor as a redox-regulated target. Immunol Cell Biol. 2008;86:232-238. (Pubitemid 351430803)
32. Verschuren L, Lindeman JH, van Bockel JH, Abdul-Hussien H, Kooistra T, Kleemann R. Up-regulation and coexpression of MIF and matrix metalloproteinases in human abdominal aortic aneurysms. Antioxid Redox Signal. 2005;7:1195-1202. (Pubitemid 41232515)
33. Pan JH, Lindholt JS, Sukhova GK, Baugh JA, Henneberg EW, Bucala R, Donnelly SC, Libby P, Metz C, Shi GP. Macrophage migration inhibitory factor is associated with aneurysmal expansion. J Vasc Surg. 2003;37: 628-635. (Pubitemid 36350910)
34. Grigoryants V, Hannawa KK, Pearce CG, Sinha I, Roelofs KJ, Ailawadi G, Deatrick KB, Woodrum DT, Cho BS, Henke PK, Stanley JC, Eagleton MJ, Upchurch GR. Tamoxifen up-regulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic aneurysms. J Vasc Surg. 2005;41:108-114. (Pubitemid 40197505)